NKAIN2 and prostate carcinoma: To further assess the frequency of genomic alterations of NKAIN2, fluorescence in situ hybridization (FISH) analysis was performed on tissue microarrays (TMAs) containing 318 prostate cancer samples, including 194 cases from China and 124 cases from UK.